|Articles|June 15, 2004
Topical cyclosporine can handle more than dry-eye disease
Any T-cell-mediated disease benefits from therapy without affecting other inflammatory pathways
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
2
Last year in glaucoma at EnVision Summit 2025
3
Metformin use associated with reduced incidence of intermediate AMD
4
NeuroOp Guru: Understanding optic disc cupping after optic neuritis
5
























